The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

I am an 84-year-old male in fairly good health for my age. I take 8-10 pills a day, including two over-the-counter ...

A study confirmed that side effects like pancreatitis and kidney damage are possible while taking GLP-1s like Ozempic. Here's ...

Common Side Effects has been such an oddity ever since it was first announced to be in the works. The initial reveal of the series noted some of the great television minds behind it bringing it to ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

FDA approves Symbravo for acute migraine relief, combining rizatriptan and meloxicam. Discover its unique benefits and fast ...

Although the Dow Jones EuroStoxx 50 was only introduced in February 1998, its prices were calculated retroactively back to the year 1986. (read more) The EuroStoxx 50 consists of the shares of the ...

Johnaé De Felicis is a contributing writer for Newsweek. As a journalist, she covers a variety of topics that include travel and technology. The credit card and travel rewards enthusiast received ...